genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Cancer
Changing Carcinogenic Cells in the Lungs with Novel Technology
Gastrointestinal Disorders
GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen
Cancer
Molecular Anchor Creates More Effective CAR T Immunotherapies
Cancer
White House Continues Dedication to “End Cancer as We Know It”
Cancer
Molecular Pathways Used by Metastatic Cancer Cells Uncovered
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
OMICs
Reflections on the Double Helix’s Platinum Anniversary
Artificial Intelligence
AI and Computational Design Advance Protein Engineering
Bioprocessing
In Pursuit of Rare, Subtle, and Fleeting Post-Translational Modifications
Infectious Diseases
Tripledemic Rouses Vaccine Developers and Variant Trackers
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Latest
All
News
A-Lists
More
Artificial Intelligence
Inside VC: Samir Kaul of Khosla Ventures on Evaluating and Managing Risk in 2023
Bayer
Top 10 Ambition: Bayer Aims for $10 Billion in Cancer Drug Sales by 2030
Gene Therapy
StockWatch: Seven Analysts Cut Price Target for Taysha on FDA Advice, Job Cuts
CRISPR
Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
Financing
EY Eyes Comeback for Biopharma M&A
Coronavirus
Developing the Next Generation of SARS-CoV-2 Vaccines
Artificial Intelligence
Zero-Shot Moonshot: Absci Uses AI Platform to Create and Validate de novo Antibodies
Leukemia
StockWatch: Patient Death Rattles Magenta Therapeutics, Analysts
Cell Therapy
Hit Pause: The Read-Across to Graphite Bio’s CEDAR Sickle Cell Trial Suspension
Gene Therapy
Rough Passage: Gene Therapy Developer Hunkers Down after Job, Pipeline Cuts
Kinases
Incyte Moves to Broaden Revenue beyond Jakafi
Autoimmune Disorders
Sanofi Extends Deal with CytoReason to License IBD Disease Modeling
Infectious Diseases
StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
Drug Discovery
NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno-Oncology Programs
Genome Editing
A16z’s Vijay Pande: Why Gene Editing Will Soon Be “Off to the Races”
Artificial Intelligence
Engineering Biology: a16z’s Vijay Pande Discusses Shift from Bespoke Drugs
CRISPR-Cas9
Arbor and Vertex to Advance Reverse Transcriptase Genetic Medicines
Financing
StockWatch: Shares Double for Targets of 3 Buyout Deals Announced at JPM
GEN Edge
Reporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk
GEN Edge
Reporter’s Notebook: Day 2 at the J.P. Morgan Healthcare Conference
Artificial Intelligence
Biotech Leaders Discuss Therapeutic Breakthroughs at the WuXi AppTec Global Forum
Biomarker Discovery
Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform
GEN Edge
Reporter’s Notebook: Opening Day at the J.P. Morgan Healthcare Conference
Whole-Genome Analysis
At JPM, Illumina Announces African-American Sequencing Collaboration
Cancer
StockWatch: Investors Embrace Geron’s Comeback Story
Drug Discovery
PhoreMost Achieves Target Discovery Milestone with Boehringer Ingelheim
Cell Therapy
Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells
Oncologics
Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment
Eye Disorders
Opus Genetics Acquires Two Gene Therapy Candidates for Inherited Retinal Diseases
Bioprocessing
From Smudge to Sequence: Quantum-Si Commercializes the First Single-Molecule Protein NGS Platform
Load more
Scroll Up
Login
Subscribe